IonQ (NYSE:IONQ) Stock

IONQ INC

IonQ

IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.

IonQ Inc

IonQ, Inc. Redeemable warrants, each whole warrant exercisable for one share of Common Stock, each at an exercise price of $11.50 per share

WIIM

Royal Caribbean Cruises shares are trading lower after Morgan Stanley cut its price target on the stock from $270 to $220.

Nokia Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) shares are trading lower premarket at the last check Thursday. The company expanded its partnership with CoreGo <a target="_blank" href="https://www.globenewswire.com/news-release/2025/04/10/3058993/0/en/Nokia-Digita-and-CoreGo-collaborate-to-enhance-the-customer-experience-at-large-events.html" rel="noreferrer noopener">to</a> deliver secure, reliable data transmission for major Finnish and international events.
CoreGo's POS system, integrated with Nokia's Digital Automation Cloud (DAC) private wireless network, allows event organizers to deploy and move a reliable network as needed, streamlining on-site payments and operations.
The solution delivers secure, real-time data transfer essential for systems like inventory, payments, access control, and ticket validation—meeting the demands of modern events.
Michael Aspinall, Head of Sales, Enterprise Campus Edge, Europe at Nokia stated, "Private 5G networks deployed with powerful edge cloud processing capabilities are transforming the event industry. Event visitors now have secure access to well-connected services from the moment they purchase their ticket to when they depart the venue."
"We have successfully collaborated with Digita and CoreGo on multiple projects, and it is great to see that private 5G technology proves its capability in securing reliable data transmission at large events,"&nbsp;
Over the past two years, this collaboration has supported numerous deployments, enhancing connectivity for sports and festival organizers and improving the experience for more than 2 million attendees across Europe.
Yesterday, the company, along with Telia and the&nbsp;Finnish Defense Forces,&nbsp;completed the world's first successful 5G standalone slice handover across<a target="_blank" href="https://www.benzinga.com/news/contracts/25/04/44714574/nokia-telia-break-ground-with-live-5g-slice-trial-across-three-nations-for-defense-operations" rel="noreferrer noopener"> multiple countries&nbsp;on&nbsp;a live network</a>.
Investors can gain exposure to the stock via Shares U.S. Digital Infrastructure and Real Estate ETF (NYSE:<a href="https://www.benzinga.com/stock/IDGT#NYSE" target="_blank" rel="noreferrer noopener"> IDGT</a>) and Defiance Connective Technologies ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIXG#NASDAQ">SIXG</a>).
<h2 class="wp-block-heading">Nokia Stock Prediction For 2025</h2>
Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.
Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Nokia, an investor could make an assessment about a stock's long term prospects using a moving average and trend line. If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Nokia, the 200-day moving average sits at $4.46, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, which is below the current price of $4.93. For more on charts and trend lines, <a href="https://pro.benzinga.com/">see a description here.</a>
Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.
Price Action: NOK shares are down 1.83% to $4.84&nbsp;premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/04/44714574/nokia-telia-break-ground-with-live-5g-slice-trial-across-three-nations-for-defense-operations" target="_blank" rel="noreferrer noopener">Nokia, Telia Break Ground With Live 5G Slice Trial Across Three Nations For Defense Operations</a></li>
</ul>
Photo via Shutterstock

Equities

Large Cap

News

Contracts

Movers

Tech

SIXG

Nokia's Private 5G Hits The Road With CoreGo For Events Across Europe

AMZN

Amazon shares are trading lower on overall market weakness and after Truist Securities cut its price target on the stock from $265 to $230.

General

SNOW

Snowflake Achieves Department of Defense IL5 Authorization

CarMax, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) shares are trading higher after the company reported<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44730762/carmax-reports-fourth-quarter-and-fiscal-year-2025-results" rel="noreferrer noopener">&nbsp;fourth-quarter&nbsp;earnings results</a>.
<ul>
<li>Quarterly sales of $6 billion beat the street view of $5.96 billion.</li>
<li>Retail used unit sales rose by 6.2% Y/Y</li>
<li>Comparable store used unit sales increased by 5.1% Y/Y</li>
<li>Wholesale units increased 3.1% Y/Y.</li>
<li>The company reported earnings per share of 58 cents, missing the&nbsp;analyst&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">consensus estimate of 68 cents</a>.</li>
<li>CarMax Auto Finance income was $159.3 million, an increase of 8.2 % year over year (Y/Y)</li>
<li>The provision for loan losses stood at $68.3 million&nbsp;vs. $71.6 million a year ago quarter.</li>
<li>Gross profit per retail used unit was&nbsp;$2,322 (up $71 per unit), and gross profit per wholesale unit was&nbsp;$1,045 (down $75 per unit).</li>
<li>The Extended Protection Plan margin increased by&nbsp;$10 per retail unit to&nbsp;$580.</li>
<li>In the&nbsp;fourth quarter, the company repurchased 1.2 million shares of common stock for&nbsp;$98.5&nbsp;million. </li>
</ul>
Buyback: As of Feb. 28, the company had $1.94 billion remaining available for repurchase under the outstanding authorization.
The company exited the quarter with cash and equivalents worth $247 million. Restricted cash from collections on auto loans receivable totaled $559.1 million.
Inventories at quarter-end stood at $3.935 billion.
Outlook: For fiscal year 2026, the company plans to open new store growth of six locations, as well as four <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">stand-alone reconditioning/auction centers</a>.
The company projects capital expenditures of around $575 million in FY26.
The year-over-year increase is mainly due to the timing of land purchases, which were deferred from fiscal year 2025 to fiscal year 2026.
Investors can gain exposure to the stock via&nbsp;Valued Advisers Trust Kovitz Core Equity ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQTY#NYSE">EQTY</a>) and&nbsp;Invesco S&amp;P 500 Equal Weight Consumer Discretionary ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSPD#NYSE">RSPD</a>).
Price Action:&nbsp;KMX shares are trading higher by&nbsp;6.44% to&nbsp;$86.66 premarket at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44729572/us-stocks-likely-to-open-lower-ahead-of-march-inflation-release-expert-highlights-fairly-weak-returns-after-5-gains-in-sp-500" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Lower Ahead Of March Inflation Release: Expert Highlights &#8216;Fairly Weak Returns&#8217; After 5%+ Gains In S&amp;P 500</a></li>
</ul>
Image: Shutterstock

Earnings

Guidance

EQTY

RSPD

CarMax Accelerates Used Car Sales Growth, Despite Earnings Miss

GIII

G-III Apparel Group Signs Licensing Agreement With ALDO Group For G.H.BASS Footwear, Bags And Small Leather Goods

TTEK

Tetra Tech Wins £36M Multiple-Award Contract To Provide Comprehensive Water Infrastructure Services In UK

Guggenheim analyst Michael Schmidt reiterates BeiGene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>) with a Buy and maintains $348 price target.

Price Target

Reiteration

Analyst Ratings

Guggenheim Reiterates Buy on BeiGene, Maintains $348 Price Target

United States Steel Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) has been red-hot until the morning of April 10. After a powerful run, shares are taking a hit i<a href="https://www.benzinga.com/quote/X/news">n premarket trading</a>, down 10.04% as of 7:55 AM Eastern Time. The culprit? <a href="https://www.benzinga.com/topic/donald-trump">President Donald Trump</a>'s latest curveball on the Nippon Steel deal.
X stock had soared 38.47% year-to-date, 28.46% in the past month and 10.64% this week. 
But that rally now faces a rude interruption, thanks to Trump&#8217;s sudden <a href="https://www.reuters.com/markets/deals/trump-says-he-does-not-want-see-us-steel-go-japan-2025-04-09/">declaration</a>: "We don't want to see it go to Japan."
Read More: <a href="https://www.benzinga.com/news/global/25/04/44725016/us-steel-stock-tumbles-as-trump-says-we-dont-want-to-see-it-go-to-japan">US Steel Stock Tumbles As Trump Says &#8216;We Don&#8217;t Want To See It Go To Japan&#8217;</a>
<h2 class="wp-block-heading">Bullish Momentum Meets Political Whiplash</h2>
Trump's comment directly undercuts hopes that Nippon's $14 billion bid for U.S. Steel might finally move forward, reported Reuters. That's despite Trump himself directing a national security panel just two days earlier to give the deal another look. White House officials, meanwhile, offered little clarity: "Everything's always on the table with the president."
Investors, understandably, are spooked. 
X stock fell to $39.77 in premarket trading &#8211; well below Nippon's $55-per-share offer and a sharp reversal from recent highs.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0410"><img loading="lazy" decoding="async" width="628" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10081241/Screenshot-2025-04-10-at-5.42.19-PM.png" alt="" class="wp-image-865802" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10081241/Screenshot-2025-04-10-at-5.42.19-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10081241/Screenshot-2025-04-10-at-5.42.19-PM-300x236.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0410">Chart created using Benzinga Pro</a>
<h2 class="wp-block-heading">X Stock Technicals Remain Strong, For Now</h2>
Despite the dip, the technical setup remains bullish for now. X stock, $45.14 (as of the last close), is comfortably above the eight-day simple moving average of $42.58, the 20-day at $42.02, and the 50-day at $39.52. Even the 200-day simple moving average of $37.78 has been left behind.
The Moving Average Convergence Divergence (MACD) indicator is at 1.37, and the Relative Strength Index is at a robust 63.85—both suggesting recent buying strength.
<h2 class="wp-block-heading">Will The Deal Collapse Or Just The Rally?</h2>
Political interference has haunted this deal from the beginning. After former President Joe Biden blocked the merger in January, the companies sued the Committee on Foreign Investment in the United States (CFIUS), alleging unfair treatment. 
A temporary truce emerged last month as all parties agreed to pause litigation and re-review the proposal.
But Trump's latest remarks could derail that detente and the stock rally along with it. For now, technicals say bullish. But price action this morning is saying: buckle up.
Read Next: 
<ul>
<li><a href="https://benzinga.com/markets/25/04/44727180/cramer-praises-trump-for-pushback-on-nippon-dumper-steel-calls-the-block-a-smart-move">Cramer Praises Trump For Pushback On Nippon &#8216;Dumper&#8217; Steel, Calls The Block A &#8216;Smart Move&#8217;</a></li>
</ul>
Photo: Shutterstock

Technicals

Commodities

Markets

Trading Ideas

Trump Torpedoes US Steel Deal, X Stock Tumbles Despite Bullish Chart

Wells Fargo analyst Jeff Cantwell upgrades Toast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) from Underweight to Overweight and raises the price target from $30 to $39.

Upgrades

TOST

Wells Fargo Upgrades Toast to Overweight, Raises Price Target to $39

ARQQ

Arqit Quantum Announced RSG Telecom Signed Test And Integration License For Arqit's NetworkSecure

In the latest quarter, 12 analysts provided ratings for Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>), showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">8</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $13.67, with a high estimate of $18.00 and a low estimate of $10.00. This current average is unchanged from the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2025/1744290098_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Rivian Automotive among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Vijay Rakesh &#x7C;Mizuho &#x7C;Lowers &#x7C;Neutral &#x7C; $10.00&#x7C;$11.00 &#x7C; 
&#x7C;Alexander Potter &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Neutral &#x7C; $13.00&#x7C;$19.00 &#x7C; 
&#x7C;Mickey Legg &#x7C;Benchmark &#x7C;Maintains &#x7C;Buy &#x7C; $18.00&#x7C;$18.00 &#x7C; 
&#x7C;Vijay Rakesh &#x7C;Mizuho &#x7C;Lowers &#x7C;Neutral &#x7C; $11.00&#x7C;$13.00 &#x7C; 
&#x7C;Ronald Jewsikow &#x7C;Guggenheim &#x7C;Lowers &#x7C;Buy &#x7C; $16.00&#x7C;$18.00 &#x7C; 
&#x7C;John Murphy &#x7C;B of A Securities &#x7C;Lowers &#x7C;Underperform &#x7C; $10.00&#x7C;$13.00 &#x7C; 
&#x7C;Colin Langan &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $14.00&#x7C;$11.00 &#x7C; 
&#x7C;Chris Pierce &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $17.00&#x7C;$14.00 &#x7C; 
&#x7C;Vijay Rakesh &#x7C;Mizuho &#x7C;Raises &#x7C;Neutral &#x7C; $13.00&#x7C;$11.00 &#x7C; 
&#x7C;Dan Levy &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $14.00&#x7C;$13.00 &#x7C; 
&#x7C;Joseph Spak &#x7C;UBS &#x7C;Raises &#x7C;Neutral &#x7C; $14.00&#x7C;$11.00 &#x7C; 
&#x7C;Jordan Levy &#x7C;Truist Securities &#x7C;Raises &#x7C;Hold &#x7C; $14.00&#x7C;$12.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Rivian Automotive. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Rivian Automotive compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Rivian Automotive's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Rivian Automotive's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RIVN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Rivian Automotive analyst ratings.</a>
<h2>Get to Know Rivian Automotive Better</h2>
Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues primarily from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.
<h3>A Deep Dive into Rivian Automotive's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Rivian Automotive showcased positive performance, achieving a revenue growth rate of 31.86% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Rivian Automotive's net margin is impressive, surpassing industry averages. With a net margin of -42.91%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Rivian Automotive's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -11.95% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Rivian Automotive's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -5.01%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.87, Rivian Automotive adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RIVN

Breaking Down Rivian Automotive: 12 Analysts Share Their Views

Guggenheim analyst Subbu Nambi maintains Neogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) with a Buy and lowers the price target from $15 to $13.

NEOG

Guggenheim Maintains Buy on Neogen, Lowers Price Target to $13

Ratings for Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Doximity, revealing an average target of $69.67, a high estimate of $90.00, and a low estimate of $43.00. Witnessing a positive shift, the current average has risen by 22.46% from the previous average price target of $56.89.
<img src="https://www.benzinga.com/files/images/story/2025/1744290090_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Doximity is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Jailendra Singh &#x7C;Truist Securities &#x7C;Lowers &#x7C;Hold &#x7C; $58.00&#x7C;$65.00 &#x7C; 
&#x7C;Steven Valiquette &#x7C;Mizuho &#x7C;Raises &#x7C;Neutral &#x7C; $65.00&#x7C;$55.00 &#x7C; 
&#x7C;David Roman &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Neutral &#x7C; $80.00&#x7C;$58.00 &#x7C; 
&#x7C;Michael Cherny &#x7C;Leerink Partners &#x7C;Raises &#x7C;Outperform &#x7C; $90.00&#x7C;$60.00 &#x7C; 
&#x7C;Richard Close &#x7C;Canaccord Genuity &#x7C;Raises &#x7C;Hold &#x7C; $71.00&#x7C;$60.00 &#x7C; 
&#x7C;Brian Peterson &#x7C;Raymond James &#x7C;Raises &#x7C;Outperform &#x7C; $83.00&#x7C;$65.00 &#x7C; 
&#x7C;Stan Berenshteyn &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $55.00&#x7C;$43.00 &#x7C; 
&#x7C;Scott Berg &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $82.00&#x7C;$65.00 &#x7C; 
&#x7C;Stan Berenshteyn &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $43.00&#x7C;$41.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Doximity. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Doximity compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Doximity's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Doximity's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/DOCS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Doximity analyst ratings.</a>
<h2>About Doximity</h2>
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
<h3>Unraveling the Financial Story of Doximity</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Over the 3M period, Doximity showcased positive performance, achieving a revenue growth rate of 24.63% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 44.6%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Doximity's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.55% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Doximity's ROA stands out, surpassing industry averages. With an impressive ROA of 6.57%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Doximity's debt-to-equity ratio is below the industry average at 0.01, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DOCS

The Analyst Verdict: Doximity In The Eyes Of 9 Experts

During the last three months, 4 analysts shared their evaluations of Assurant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Assurant, presenting an average target of $231.75, a high estimate of $250.00, and a low estimate of $223.00. This current average reflects an increase of 2.43% from the previous average price target of $226.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1744290081_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Assurant among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;John Barnidge &#x7C;Piper Sandler &#x7C;Maintains &#x7C;Overweight &#x7C; $223.00&#x7C;$223.00 &#x7C; 
&#x7C;Tommy McJoynt &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $224.00&#x7C;$230.00 &#x7C; 
&#x7C;Tommy McJoynt &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Outperform &#x7C; $230.00&#x7C;$212.00 &#x7C; 
&#x7C;Mark Hughes &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $250.00&#x7C;$240.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Assurant. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Assurant compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Assurant's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Assurant's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AIZ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Assurant analyst ratings.</a>
<h2>About Assurant</h2>
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
<h3>Breaking Down Assurant's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Assurant displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 4.08%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Assurant's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 6.48%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Assurant's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.89%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Assurant's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.57%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.41, caution is advised due to increased financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Assurant Through The Eyes Of 4 Analysts

Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Liquidia, revealing an average target of $28.25, a high estimate of $34.00, and a low estimate of $25.00. This upward trend is evident, with the current average reflecting a 9.71% increase from the previous average price target of $25.75.
<img src="https://www.benzinga.com/files/images/story/2025/1744290051_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Liquidia among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Serge Belanger &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $25.00&#x7C;$25.00 &#x7C; 
&#x7C;Greg Harrison &#x7C;Scotiabank &#x7C;Raises &#x7C;Sector Outperform&#x7C; $34.00&#x7C;$30.00 &#x7C; 
&#x7C;Andrew Fein &#x7C;HC Wainwright &amp; Co. &#x7C;Maintains &#x7C;Buy &#x7C; $29.00&#x7C;$29.00 &#x7C; 
&#x7C;Serge Belanger &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $25.00&#x7C;$19.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Liquidia. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Liquidia compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Liquidia's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Liquidia's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/LQDA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Liquidia analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Liquidia</h2>
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
<h3>Unraveling the Financial Story of Liquidia</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Liquidia's revenue growth over a period of 3M has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -35.62%. This indicates a decrease in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -1315.36%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Liquidia's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -40.86%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Liquidia's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -15.88%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Liquidia's debt-to-equity ratio is below the industry average at 1.58, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LQDA

Breaking Down Liquidia: 4 Analysts Share Their Views

During the last three months, 13 analysts shared their evaluations of Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">13</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Bitdeer Technologies, revealing an average target of $22.65, a high estimate of $30.00, and a low estimate of $12.00. Observing a downward trend, the current average is 6.52% lower than the prior average price target of $24.23. 
<img src="https://www.benzinga.com/files/images/story/2025/1744290042_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A clear picture of Bitdeer Technologies's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Lowers &#x7C;Buy &#x7C; $12.00&#x7C;$25.00 &#x7C; 
&#x7C;John Todaro &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $15.00&#x7C;$18.00 &#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Lowers &#x7C;Buy &#x7C; $25.00&#x7C;$30.00 &#x7C; 
&#x7C;Darren Aftahi &#x7C;Roth MKM &#x7C;Lowers &#x7C;Buy &#x7C; $23.50&#x7C;$29.00 &#x7C; 
&#x7C;Mark Palmer &#x7C;Benchmark &#x7C;Lowers &#x7C;Buy &#x7C; $24.00&#x7C;$29.00 &#x7C; 
&#x7C;John Todaro &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $18.00&#x7C;$22.00 &#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $30.00&#x7C;$30.00 &#x7C; 
&#x7C;Mike Colonnese &#x7C;HC Wainwright &amp; Co. &#x7C;Lowers &#x7C;Buy &#x7C; $21.00&#x7C;$22.00 &#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $30.00&#x7C;$30.00 &#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Raises &#x7C;Buy &#x7C; $30.00&#x7C;$22.00 &#x7C; 
&#x7C;John Todaro &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $22.00&#x7C;$22.00 &#x7C; 
&#x7C;Kevin Cassidy &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $22.00&#x7C;$22.00 &#x7C; 
&#x7C;John Todaro &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $22.00&#x7C;$14.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Bitdeer Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Bitdeer Technologies compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Bitdeer Technologies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Bitdeer Technologies's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BTDR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Bitdeer Technologies analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>All You Need to Know About Bitdeer Technologies</h2>
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway.
<h3>Bitdeer Technologies's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Bitdeer Technologies's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 11.27%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -770.69%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Bitdeer Technologies's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -133.42%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Bitdeer Technologies's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -40.85%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 1.03, Bitdeer Technologies faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BTDR

Assessing Bitdeer Technologies: Insights From 13 Financial Analysts

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B of A Securities analyst Joshua Dennerlein initiated coverage on MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) with a Neutral rating and announced a price target of $585. MSCI shares closed at $549.33 on Wednesday. <a href="https://www.benzinga.com/quote/MSCI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho initiated coverage on MannKind Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNKD#NASDAQ">MNKD</a>) with an Outperform rating and announced a price target of $12. MannKind shares closed at $4.69 on Wednesday. <a href="https://www.benzinga.com/quote/MNKD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Kelly Shi initiated coverage on Verastem, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>) with a Buy rating and announced a price target of $15. Verastem shares closed at $5.28 on Wednesday. <a href="https://www.benzinga.com/quote/VSTM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Tami Zakaria initiated coverage on Westinghouse Air Brake Technologies Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) with a Neutral rating and announces Price Target of $175. Westinghouse Air Brake shares closed at $175.82 on Wednesday. <a href="https://www.benzinga.com/quote/WAB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Annabel Samimy initiated coverage on Ligand Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGND#NASDAQ">LGND</a>) with a Buy rating and announced a price target of $143. Ligand Pharmaceuticals shares closed at $103.85 on Wednesday.  <a href="https://www.benzinga.com/quote/LGND/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying LGND stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="642" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10085936/image-67-1024x642.png" alt="" class="wp-image-865923" style="width:490px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10085936/image-67-1024x642.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10085936/image-67-300x188.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10085936/image-67-768x482.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10085936/image-67.png 1087w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44710375/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>
Photo via Shutterstock

Initiation

Pre-Market Outlook

LGND

MNKD

MSCI

VSTM

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Lennar's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) short percent of float has fallen 4.13% since its last report. The company recently reported that it has 8.60 million shares sold short, which is 4.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Lennar Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744290031_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Lennar has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Lennar's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Lennar's peer group average for short interest as a percentage of float is 10.58%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Do Investors Really Feel About Lennar?

Penumbra's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) short percent of float has fallen 9.64% since its last report. The company recently reported that it has 1.22 million shares sold short, which is 4.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.96 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Penumbra Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744290025_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Penumbra has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Penumbra's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Penumbra's peer group average for short interest as a percentage of float is 4.40%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is Penumbra Gaining or Losing Market Support?

Press Releases

IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program

IonQ Expands Quantum Networking Patent Portfolio to Meet Strong Market Demand for Secure Communications

Defiance Launches IONX: 2X Leveraged ETF for IonQ

Small Cap

Opinion

Quantum Computing Just Took Another Giant Leap--What It Means for Investors

IonQ Executive Chair Joins Panel with NVIDIA CEO to Discuss Quantum at NVIDIA's First-Ever Quantum Day

IonQ and Ansys Achieve Major Quantum Computing Milestone – Demonstrating Quantum Outperforming Classical Computing

GraniteShares 2x Long IONQ Daily ETF (IONL), GraniteShares 2x Long VRT Daily ETF (VRTL), and GraniteShares 2x Long RDDT Daily ETF (RDTL) Launch Today.

IonQ Announces Global Availability of Forte Enterprise Through Amazon Braket and IonQ Quantum Cloud

IonQ Selected by DARPA for Quantum Benchmarking Initiative (QBI) to Advance Quantum Computing

IonQ Celebrates World Quantum Day with New Quantum Advancements and Customer Collaborations

Comments

IonQ

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL